Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults.
about
Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendationsQT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac RepolarizationPharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects.Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects.Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects.Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy AdultsPharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Isavuconazole: A Review in Invasive Aspergillosis and Mucormycosis.Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4.Isavuconazole: is there a need for a new antifungal?Pharmacokinetic and Pharmacodynamic Evaluation of the Drug-Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects.Isavuconazole shortens the QTc interval.Two Phase 1, Open-Label, Mass Balance Studies to Determine the Pharmacokinetics of 14 C-Labeled Isavuconazonium Sulfate in Healthy Male Volunteers.Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients.Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.
P2860
Q28067726-836A5F57-AF39-4A69-9CDD-50E2EE3220E0Q33837720-AB195280-4A59-4896-9D26-EDB8EDEB1021Q37631771-C6AA05F8-B424-4FFC-AE30-654A39B6287BQ37631831-501C5E1E-1D7A-4549-ACA1-87D4E5836A83Q37631841-8FD015E6-AD8C-4A83-B66F-106D04CD4BDFQ37631935-0BC05530-1424-408A-8588-3B26D73B08EEQ38681635-28198525-9173-4A7E-A0A9-A0E292F44894Q38987096-44873F23-6FC9-4B29-8850-D7A2A2BB26B5Q39443748-E4C9DF3B-E2A8-4CF0-B4F7-17417C6C4455Q40273512-3FB4DEE5-6AA8-4A9E-B9AA-323E7AC2356BQ42323175-9C97F0F2-74B4-48A9-B720-4FC06A2D1C9BQ47409728-DEC9A52A-6119-4FC8-97C3-70301930DCD1Q47954619-E0AD8C7A-BC45-4D2C-8B73-F31620F7368DQ48350049-F4332A63-2B2D-4E6C-A053-69986DA66357Q53477089-2ED2321A-7475-4628-B1A8-AC051AB7A990Q54214603-B5FD0C88-ADE3-4051-8D48-8206C01CBAA5
P2860
Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic Assessment of ...... Tacrolimus in Healthy Adults.
@en
Pharmacokinetic Assessment of ...... Tacrolimus in Healthy Adults.
@nl
type
label
Pharmacokinetic Assessment of ...... Tacrolimus in Healthy Adults.
@en
Pharmacokinetic Assessment of ...... Tacrolimus in Healthy Adults.
@nl
prefLabel
Pharmacokinetic Assessment of ...... Tacrolimus in Healthy Adults.
@en
Pharmacokinetic Assessment of ...... Tacrolimus in Healthy Adults.
@nl
P2093
P2860
P356
P1476
Pharmacokinetic Assessment of ...... Tacrolimus in Healthy Adults.
@en
P2093
Amit Desai
Andreas H Groll
Christopher Lademacher
Corrie Howieson
Debra Mandarino
Donna Kowalski
Helene Pearlman
Robert Townsend
P2860
P356
10.1002/CPDD.284
P577
2016-06-08T00:00:00Z